Torthaí cuardaigh - Durez, Patrick
- 1 - 20 toradh as 50 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
-
2
-
3
Seven-year follow-up of infliximab therapy in rheumatoid arthritis patients with severe long-standing refractory disease: attrition rate and evolution of disease activity de réir Vander Cruyssen, Bert, Durez, Patrick, Westhovens, Rene, De Keyser, Filip
Foilsithe / Cruthaithe 2010Téacs -
4
MRI of Hands with Early Rheumatoid Arthritis: Usefulness of Three-Point Dixon Sequences to Quantitatively Assess Disease Activity de réir Kirchgesner, Thomas, Stoenoiu, Maria, Durez, Patrick, Michoux, Nicolas, Vande Berg, Bruno
Foilsithe / Cruthaithe 2022Téacs -
5
A rare case of tuberculosis-induced hypercalcemia de réir Wauthier, Loris, Theunssens, Xavier, Durez, Patrick, Fillée, Catherine, Maisin, Diane, Gruson, Damien
Foilsithe / Cruthaithe 2020Téacs -
6
Validation of the ABILHAND questionnaire as a measure of manual ability in patients with rheumatoid arthritis de réir Durez, Patrick, Fraselle, Virginie, Houssiau, Frédéric, Thonnard, Jean‐Louis, Nielens, Henri, Penta, Massimo
Foilsithe / Cruthaithe 2007Téacs -
7
Identification of poor prognostic joint locations in an early rheumatoid arthritis cohort at risk of rapidly progressing disease: a post-hoc analysis of the Phase III AGREE study de réir Durez, Patrick, Westhovens, Rene, Baeke, Femke, Elbez, Yedid, Robert, Sofie, Ahmad, Harris A.
Foilsithe / Cruthaithe 2022Téacs -
8
Response to the commentary 'Pooled indices to measure rheumatoid arthritis activity: a good reflection of the physician's mind' de réir Vander Cruyssen, Bert, Durez, Patrick, Westhovens, Rene, Vastesaeger, Nathan, Geldhof, Anja, De Keyser, Filip
Foilsithe / Cruthaithe 2006Téacs -
9
Anti-TNF Induced Sarcoidosis-Like Disease in Rheumatoid Arthritis Patients: Review Cases from the RA UCLouvain Brussels Cohort de réir Theunssens, Xavier, Bricman, Laura, Dierckx, Stéphanie, Sapart, Emilie, Sokolova, Tatiana, Avramovska, Aleksandra, Durez, Patrick
Foilsithe / Cruthaithe 2022Téacs -
10
The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues for the optimization of rituximab treatment strategies de réir Vander Cruyssen, Bert, Durez, Patrick, Westhovens, Rene, Kaiser, Marie-Joelle, Hoffman, Ilse, De Keyser, Filip
Foilsithe / Cruthaithe 2010Téacs -
11
A Nationwide Survey on Patient’s versus Physician´s Evaluation of Biological Therapy in Rheumatoid Arthritis in Relation to Disease Activity and Route of Administration: The Be-Rai... de réir De Mits, Sophie, Lenaerts, Jan, Vander Cruyssen, Bert, Mielants, Herman, Westhovens, René, Durez, Patrick, Elewaut, Dirk
Foilsithe / Cruthaithe 2016Téacs -
12
Human carbamylome description identifies carbamylated α2-macroglobulin and hemopexin as two novel autoantigens in early rheumatoid arthritis de réir Sidiras, Paschalis, Lechanteur, Jessica, Imbault, Virginie, Sokolova, Tatiana, Durez, Patrick, Gangji, Valérie, Communi, David, Rasschaert, Joanne
Foilsithe / Cruthaithe 2021Téacs -
13
Baricitinib inhibits structural joint damage progression in patients with rheumatoid arthritis—a comprehensive review de réir Emery, Paul, Durez, Patrick, Hueber, Axel J., de la Torre, Inmaculada, Larsson, Esbjörn, Holzkämper, Thorsten, Tanaka, Yoshiya
Foilsithe / Cruthaithe 2021Téacs -
14
Baseline Objective Inflammation by Magnetic Resonance Imaging as a Predictor of Therapeutic Benefit in Early Rheumatoid Arthritis With Poor Prognosis de réir Ahmad, Harris A., Baker, Joshua F., Østergaard, Mikkel, Emery, Paul, Durez, Patrick, Ye, June, Banerjee, Subhashis, Conaghan, Philip G.
Foilsithe / Cruthaithe 2020Téacs -
15
Upadacitinib improves patient-reported outcomes vs placebo or adalimumab in patients with rheumatoid arthritis: results from SELECT-COMPARE de réir Strand, Vibeke, Tundia, Namita, Bergman, Martin, Ostor, Andrew, Durez, Patrick, Song, In-Ho, Enejosa, Jeffrey, Schlacher, Casey, Song, Yan, Fleischmann, Roy
Foilsithe / Cruthaithe 2021Téacs -
16
Common Transcriptomic Effects of Abatacept and Other DMARDs on Rheumatoid Arthritis Synovial Tissue de réir Triaille, Clement, Durez, Patrick, Sokolova, Tatiana, Tilman, Gaëlle, Méric de Bellefon, Laurent, Galant, Christine, Coulie, Pierre, Lauwerys, Bernard R., Limaye, Nisha
Foilsithe / Cruthaithe 2021Téacs -
17
Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, phase II, dose-finding study de réir Alten, Rieke, Gomez-Reino, Juan, Durez, Patrick, Beaulieu, Andre, Sebba, Anthony, Krammer, Gerhard, Preiss, Ralph, Arulmani, Udayasankar, Widmer, Albert, Gitton, Xavier, Kellner, Herbert
Foilsithe / Cruthaithe 2011Téacs -
18
Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insuf... de réir Fleischmann, Roy M, Genovese, Mark C, Enejosa, Jeffrey V, Mysler, Eduardo, Bessette, Louis, Peterfy, Charles, Durez, Patrick, Ostor, Andrew, Li, Yihan, Song, In-Ho
Foilsithe / Cruthaithe 2019Téacs -
19
Tapering of biological antirheumatic drugs in rheumatoid arthritis patients is achievable and cost-effective in daily clinical practice: data from the Brussels UCLouvain RA Cohort de réir Dierckx, Stéphanie, Sokolova, Tatiana, Lauwerys, Bernard R., Avramovska, Aleksandra, de Bellefon, Laurent Meric, Toukap, Adrien Nzeusseu, Stoenoiu, Maria, Houssiau, Frédéric A., Durez, Patrick
Foilsithe / Cruthaithe 2020Téacs -
20
Serum calprotectin (S100A8/A9): a promising biomarker in diagnosis and follow-up in different subgroups of juvenile idiopathic arthritis de réir La, Céline, Lê, Phu Quoc, Ferster, Alina, Goffin, Laurence, Spruyt, Delphine, Lauwerys, Bernard, Durez, Patrick, Boulanger, Cecile, Sokolova, Tatiana, Rasschaert, Joanne, Badot, Valérie
Foilsithe / Cruthaithe 2021Téacs